{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:22:19Z","timestamp":1753273339104},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.arbres.2012.11.005","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T14:48:40Z","timestamp":1359989320000},"page":"249-260","source":"Crossref","is-referenced-by-count":13,"title":["Manifestaciones pulmonares de las enfermedades del col\u00e1geno"],"prefix":"10.1016","volume":"49","author":[{"given":"Luis","family":"G\u00f3mez Carrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Bonilla Hernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2012.11.005_bib0005","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factor over 46 year","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/RTI.0b013e3181c1acec","article-title":"Lung disease related to collagen vascular disease","volume":"24","author":"Lynch","year":"2009","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.arbres.2012.11.005_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1183\/1025448x.00034002","article-title":"Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical up date","volume":"34","author":"Grutters","year":"2006","journal-title":"Eur Respir Mon"},{"key":"10.1016\/j.arbres.2012.11.005_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/rheumatology\/kel075","article-title":"Drug-related pulmonary problems in patients with rheumatoid arthritis [editorial]","volume":"45","author":"Saravanan","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0025","first-page":"1164","article-title":"Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case report and review of the literature","volume":"14","author":"Searles","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e3283483ea5","article-title":"Biological treatment and connective tissue disease associated interstitial lung disease","volume":"17","author":"Panopoulus","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestation in rheumatoid arthritis: incident trenes and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"Supl 5","key":"10.1016\/j.arbres.2012.11.005_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-2896(10)70033-8","article-title":"Consenso para el diagn\u00f3stico de las neumon\u00edas intersticiales idiop\u00e1ticas","volume":"46","author":"Ancochea","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0045","first-page":"556","article-title":"Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases","author":"Meyer","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/rheumatology\/41.1.88","article-title":"The prevalence of rheumatoid arthritis in the general population of Spain","volume":"41","author":"Carmona","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2012.11.005_bib0055","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/BOR.0b013e3282f798ed","article-title":"Lung disease in rheumatoid arthritis","volume":"20","author":"Nannini","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0060","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277\u2013304.","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"10.1016\/j.arbres.2012.11.005_bib0065","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cause of death in rheumatoid arthritis: a population-based study","volume":"52","author":"Suzuki","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography and pulmonary function test","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0075","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","article-title":"Rheumatoid arthritis in Spain: occurrence of extra-articular manifestation and estimates of disease severity","volume":"62","author":"Carmona","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intr Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/03009749509099296","article-title":"Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis","volume":"24","author":"Luukkainen","year":"1995","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0090","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung disease: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/thx.45.8.591","article-title":"Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease","volume":"45","author":"Gilligan","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0110","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/rheumatology\/32.7.556","article-title":"Bronchoalveolar lavage in rheumatoid arthritis","volume":"32","author":"Kolarz","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0115","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathology pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0120","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.200204-373OC","article-title":"Fibroblastic foci in usual interstitial pneumonia","volume":"167","author":"Flaherty","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HDCT scanning and pulmonary function tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0049-0172(87)90021-7","article-title":"Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate","volume":"16","author":"Carson","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0135","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathology features of methotrexate-associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0145","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.122.3.1093","article-title":"Clinical response of rheumatoid arthritis- associated pulmonary fibrosis to tumour necrosis factor-alfa inhibition","volume":"122","author":"Vasallo","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0150","doi-asserted-by":"crossref","first-page":"109S","DOI":"10.1378\/chest.124.4_MeetingAbstracts.109S-a","article-title":"The treatment of interstitial lung disease associated whit rheumatoid arthritis with infliximab","volume":"124","author":"Dellapira","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0155","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Grenn","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Shoe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0165","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/bmj.329.7477.1266","article-title":"Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab","volume":"329","author":"Ostor","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.arbres.2012.11.005_bib0170","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"J Rheumaotology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0175","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/keh464","article-title":"Guidelines and Audit Working Group (SGAWG). Update on the British Society for Rheumatology guidelines for prescribing TNF alfa blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)","volume":"44","author":"Ledingham","year":"2005","journal-title":"Rheumatology"},{"issue":"Suppl 1","key":"10.1016\/j.arbres.2012.11.005_bib0185","first-page":"83","article-title":"Serious pulmonary complications in patients treated with leflunomide","volume":"40","author":"Balakrishnan","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0190","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2169\/internalmedicine.43.1103","article-title":"Interstitial lung disease associated with leflunomide","volume":"43","author":"Ito","year":"2004","journal-title":"Intern Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(08)60453-5","article-title":"Effect of interleukin-6 receptors inhibition with tocilizumab in patients with rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial","volume":"371","author":"Smolen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2012.11.005_bib0200","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1007\/s00296-010-1525-z","article-title":"A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab","volume":"32","author":"Kawasshiri","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.arbres.2012.11.005_bib0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jbspin.2007.10.009","article-title":"Organizing pneumonia after rituximab therapy: two cases","volume":"75","author":"Soubrier","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.arbres.2012.11.005_bib0210","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ajh.20910","article-title":"Rituximab-induced interstitial lung disease","volume":"82","author":"Wagner","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0215","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/thx.47.12.1035","article-title":"Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up","volume":"47","author":"Agust\u00ed","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0220","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0225","first-page":"1250","article-title":"Interstitial lung disease in patients whit rheumatoid arthritis: Comparison with cryptogenic fibrosing alveolitis over 5 years","volume":"33","author":"Rajasekaran","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0230","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1513\/pats.200703-045MS","article-title":"Rheumatoid lung disease","volume":"4","author":"Brown","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.arbres.2012.11.005_bib0235","first-page":"109","article-title":"N\u00f3dulos pulmonares necrobi\u00f3ticos en ausencia de artritis reumatoide. Reporte de un caso","volume":"59","author":"Espinoza-Poblano","year":"2000","journal-title":"Neumol Cir Torax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.reuma.2011.09.004","article-title":"N\u00f3dulos pulmonares reumatoides: forma de presentaci\u00f3n, m\u00e9todos diagn\u00f3sticos y evoluci\u00f3n a prop\u00f3sito de 5 casos","volume":"8","author":"G\u00f3mez Herrero","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.arbres.2012.11.005_bib0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.8.1.29","article-title":"Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis","volume":"8","author":"Caplan","year":"1953","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0250","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bmj.2.4848.1231","article-title":"An epidemiological study of rheumatoid arthritis associated with characteristic chest X-ray appearances in coal-workers","volume":"2","author":"Mial","year":"1953","journal-title":"Br Med J"},{"key":"10.1016\/j.arbres.2012.11.005_bib0255","series-title":"Manifestaciones Cardiopulmonares","author":"Mateo Soria","year":"2003"},{"key":"10.1016\/j.arbres.2012.11.005_bib0260","series-title":"Pleural Diseases","author":"Light","year":"1983"},{"key":"10.1016\/j.arbres.2012.11.005_bib0265","first-page":"325","article-title":"Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables","volume":"51","author":"Skare","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0270","first-page":"187","article-title":"Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography","volume":"19","author":"Andonopoulos","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0275","first-page":"390","article-title":"Interstitial lung disease as the first manifestation of systemic sclerosis","volume":"65","author":"Van der Kamp","year":"2007","journal-title":"Neth J Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis & Rheumatism (Arthritis Care & Research)"},{"key":"10.1016\/j.arbres.2012.11.005_bib0285","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3125","article-title":"Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort","volume":"12","author":"Assassi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.arbres.2012.11.005_bib0290","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/art.24586","article-title":"Anti-Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis","volume":"61","author":"Fertig","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0295","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1440-1843.2009.01600.x","article-title":"Non-invasive biomarkers in pulmonary fibrosis","volume":"14","author":"Prasse","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0300","first-page":"414","article-title":"Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato\/polymyositis","volume":"26","author":"Kum\u00e1novics","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0305","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/bmm.09.79","article-title":"Biomarkers in systemic sclerosis","volume":"4","author":"Castro","year":"2010","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0310","first-page":"429","article-title":"Longitudinal analysis of serum KL-6 levels in patients with systemic sclerosis: association with the activity of pulmonary fibrosis","volume":"21","author":"Yanaba","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.162.1.9903014","article-title":"Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis","volume":"162","author":"Takahashi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0320","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Scleroderma Lung Study Research Group: Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0325","first-page":"27","article-title":"Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement","volume":"28","author":"Bonella","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0330","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/art.21257","article-title":"Serum pulmonary and activation-regulated chemokine\/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis","volume":"52","author":"Kodera","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0335","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/03009740510018598","article-title":"High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement","volume":"34","author":"Nordenbaek","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0340","first-page":"1789","article-title":"High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis","volume":"33","author":"Launay","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0345","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","article-title":"Interstitial lung disease in systemic sclerosis","volume":"10","author":"Bussone","year":"2011","journal-title":"Autoimmunity Reviews"},{"key":"10.1016\/j.arbres.2012.11.005_bib0350","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathology subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0355","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0360","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0365","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0370","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.080447","article-title":"Limitations to the 6-minutewalk test in interstitial lung disease and pulmonary hypertension in scleroderma","volume":"36","author":"Garin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0375","first-page":"198","article-title":"Systemic sclerosis: an update","volume":"66","author":"Varga","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0380","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1164\/ajrccm.149.6.8004317","article-title":"Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis","volume":"149","author":"Wells","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0385","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF02242456","article-title":"A longitudinal study of pulmonary function in Danish patients with systemic sclerosis","volume":"16","author":"Jacobsen","year":"1997","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0390","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0395","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1196\/annals.1423.029","article-title":"Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?","volume":"1110","author":"Berezne","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.arbres.2012.11.005_bib0400","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10067-005-1157-y","article-title":"A randomized unblended trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis","volume":"25","author":"Nadashkevich","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0410","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.arbres.2011.01.010","article-title":"Eficacia de la ciclofosfamida en el tratamiento de la enfermedad pulmonar intersticial asociada a la esclerosis sist\u00e9mica","volume":"47","author":"Espinos","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0415","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1378\/chest.06-2861","article-title":"Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease","volume":"133","author":"Gerbino","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0425","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/BOR.0b013e3283307dc8","article-title":"Therapy for pulmonary arterial hypertension associated with systemic sclerosis","volume":"21","author":"Mathai","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Reum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0435","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/thorax.55.2.159","article-title":"Pleuropulmonary manifestation of systemic lupus erythematous","volume":"55","author":"Keane","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2012.11.005_bib0440","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000119051","article-title":"Pleural involvement in systemic autoimmune disorders","volume":"75","author":"Bouros","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2012.11.005_bib0445","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-2007-985665","article-title":"Pulmonary manifestations of systemic lupus erithematosus","volume":"28","author":"Menet","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0450","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccm.2010.05.001","article-title":"Pulmonary manifestations of systemic lupus erythematous","volume":"31","author":"Kamen","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/1479972310393758","article-title":"Connective tissue-associated interstitial lung disease: How does it differ from IPF? How should the clinical approach differ?","volume":"8","author":"Laurentis","year":"2011","journal-title":"Cron Respir Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0460","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1398-9995.2005.00761.x","article-title":"The respiratory system in connective tissue disorders","volume":"60","author":"Crestani","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.arbres.2012.11.005_bib0465","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0954-6111(99)90297-4","article-title":"Clinical and laboratory features of lupus patients with pulmonary disease","volume":"93","author":"Mochizuki","year":"1999","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0470","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0049-0172(90)90094-V","article-title":"A long-term study of interstitial lung disease in systemic lupus erythematous","volume":"20","author":"Weinrib","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0475","first-page":"507","article-title":"Pleuropulmonary abnormalities in patients with lupus erythematous: assessment with high resolution computed tomography, chest radiography and pulmonary function tests","volume":"15","author":"Sant","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0480","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","article-title":"Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis","volume":"44","author":"Tansey","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.arbres.2012.11.005_bib0485","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2009.01.002","article-title":"Respiratory manifestations of systemic lupus erythematous: old and new concepts","volume":"23","author":"Pego-Reigosa","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ndt\/gfm701","article-title":"Diffuse alveolar hemorrhage in a systemic lupus erythematous patient successfully treated with rituximab. A case report","volume":"23","author":"Nellessen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arbres.2012.11.005_bib0495","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"Prabu","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arbres.2012.11.005_bib0500","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1191\/096120300678828361","article-title":"Primary and secondary pulmonary hypertension in systemic lupus erythematous","volume":"9","author":"Pan","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.arbres.2012.11.005_bib0505","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s10067-006-0206-5","article-title":"Clinical aspects of pulmonary hypertension y patients with idiopathic pulmonary arterial hypertension","volume":"25","author":"Chung","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0510","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1378\/chest.117.1.14","article-title":"Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematous","volume":"117","author":"Robbins","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0515","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0520","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1191\/0961203304lu509oa","article-title":"Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematous","volume":"13","author":"Gonz\u00e1lez-L\u00f3pez","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.arbres.2012.11.005_bib0525","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/096120339500400405","article-title":"Acute reversible hypoxemia in systemic lupus erythematous: a new syndrome or an index of disease activity?","volume":"4","author":"Mart\u00ednez-Taboada","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.arbres.2012.11.005_bib0530","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/ard.50.12.956","article-title":"Bronchiolitis obliterans in systemic lupus erythematous: beneficial effect of intra venous cyclophosphamide","volume":"50","author":"Gondeau","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0535","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-2007-985667","article-title":"Sj\u00f6gren Syndrome","volume":"28","author":"Papiris","year":"2007","journal-title":"Semin Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0540","first-page":"831","article-title":"Pleuropulmonary abnormalities in primary Sj\u00f6gren syndrome","volume":"205","author":"Gardiner","year":"1993","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0545","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ccm.2010.05.007","article-title":"Pulmonary Involvement in Sj\u00f6gren syndrome","volume":"31","author":"Kokoski","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0550","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1378\/chest.88.2.226","article-title":"Respiratory manifestations in primary Sj\u00f6gren syndrome. A clinical, functional and histologist study","volume":"88","author":"Constantopulos","year":"1985","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rdc.2008.08.012","article-title":"Pulmonary manifestations of primary Sj\u00f6gren syndrome","volume":"34","author":"Parke","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.arbres.2012.11.005_bib0560","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","article-title":"Clinical and immunologic expression in 1010 patients","volume":"87","author":"Ramos-Casal","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.arbres.2012.11.005_bib0565","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000214841","article-title":"Pulmonary manifestations of Sj\u00f6gren syndrome","volume":"78","author":"Shi","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2012.11.005_bib0570","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial lung disease in primary Sj\u00f6gren syndrome","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2012.11.005_bib0575","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestation of primary Sj\u00f6gren syndrome: a clinical, radiological and pathologic study","volume":"171","author":"Ito","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0580","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-3083.2008.02185.x","article-title":"Anti CD20 treatment in primary Sj\u00f6gren syndrome","volume":"68","author":"Isaksen","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0585","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u00f6gren syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0590","first-page":"676","article-title":"Bronchiolitis obliterans organizing pneumonia and Sj\u00f6gren syndrome","volume":"17","author":"Matteson","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0595","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00296-008-0568-x","article-title":"Cryptogenic organizing pneumonia associated with primary Sj\u00f6gren syndrome","volume":"28","author":"Ionone","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.arbres.2012.11.005_bib0600","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.arbres.2011.01.003","article-title":"Inflamaci\u00f3n bronquial, cl\u00ednica respiratoria y funci\u00f3n pulmonar en el s\u00edndrome de Sj\u00f6gren primario","volume":"47","author":"Bellido-Casado","year":"2011","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0605","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.rmed.2011.08.009","article-title":"Small airway disease associated with Sj\u00f6gren syndrome: Clinico-pathological correlations","volume":"105","author":"Nakanishi","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0610","first-page":"47","article-title":"Bronchiectasis in primary Sj\u00f6gren syndrome: prevalence and clinical significance","volume":"28","author":"Soto-Cardenas","year":"2010","journal-title":"Clin Exp Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0615","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival mortality and causes of death inn inflammatory myopathies","volume":"39","author":"Torres","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.arbres.2012.11.005_bib0620","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-2007-985666","article-title":"Pulmonary complications of polymiosistis and dermatomyositis","volume":"28","author":"Fathi","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0625","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymiositis and dermathomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arbres.2012.11.005_bib0630","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccm.2010.05.008","article-title":"Pulmonary manifestations of the idiopathic inflammatory myopathies","volume":"31","author":"Kalluri","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0635","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","article-title":"Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis","volume":"63","author":"Fathi","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arbres.2012.11.005_bib0640","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/BOR.0b013e32833f1970","article-title":"Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls","volume":"22","author":"Labirua","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0645","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.bor.0000179949.65895.53","article-title":"Interstitial lung disease in polymiositis and dermatomyositis","volume":"17","author":"Fathi","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0650","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/qjmed\/77.1.1019","article-title":"Polimyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes","volume":"77","author":"Marguerie","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0655","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.rmed.2011.03.022","article-title":"Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias","volume":"105","author":"Watanabe","year":"2011","journal-title":"Resp Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0660","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","author":"Koreeda","year":"2010","journal-title":"Inter Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0665","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/157339710791330740","article-title":"Interstitial lung disease in idiopathic inflammatory myopathy","volume":"6","author":"Saketkoo","year":"2010","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.arbres.2012.11.005_bib0670","first-page":"1719","article-title":"Combination therapy with corticosteroids, cyclosporine A and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis","volume":"32","author":"Kameda","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arbres.2012.11.005_bib0675","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/acr.20212","article-title":"Mycophenolate mofetil for interstitial lung disease in dermatomyosistis","volume":"62","author":"Morganroth","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.arbres.2012.11.005_bib0680","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am J Respi Crit Care Med"},{"key":"10.1016\/j.arbres.2012.11.005_bib0685","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.00094910","article-title":"Idiopathic NSIP: an interstitial lung disease associated with autoimmune disorders?","volume":"38","author":"Romagnoli","year":"2011","journal-title":"Eur Respir"},{"key":"10.1016\/j.arbres.2012.11.005_bib0690","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289612003146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289612003146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T02:52:21Z","timestamp":1562640741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289612003146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0300289612003146"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2012.11.005","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}